e-therapeutics plc

Here is the public summary page for e-therapeutics plc. Please login to see the complete information for e-therapeutics plc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how e-therapeutics plc stacks up relative to its peers.


Darwin Score-4
TickerETX
Latest Price0.09 GBP as of close on 08-May-2024
3 Month price range0.09 to 0.17 GBP
Market Capitalisation56.39Mn GBP
CountryUK
RegionEurope
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryBiotechnology
Sub-IndustryBiotechnology
Description
e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet. The company was incorporated in 2001 and is based in London, the United Kingdom.
See More ...
Company URLhttps://www.etherapeutics.co.uk
See Darwins Full Analysis for e-therapeutics plc

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for e-therapeutics plc. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages-8
SentimentNews and Candle Patterns. 0
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.0
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.+4

Alerts

There are 5 live alerts for e-therapeutics plc.


Peer Comparison

There are 28 peers of e-therapeutics plc.
Asset NameIndustry GroupPerf(20d)%Asset Score
4BASEBIO UK SOCIETAS (4BB)Biotechnology-14.2-15
Abingdon Health Plc (ABDX)Biotechnology-3.7+3
Alliance Pharma plc (APH)Biotechnology+0.8+34
Angle PLC (AGL)Biotechnology-12.7-19
Aptamer Group PLC (APTA)Biotechnology+22.6+11
Arecor Therapeutics PLC (AREC)Biotechnology+3.1+7
Avacta Group PLC (AVCT)Biotechnology-26.1-14
BSF Enterprise Plc (BSFA)Biotechnology-90.1+1
Benchmark Holdings Plc (BMK)Biotechnology-16.1-16
Beximco Pharmaceuticals Limited (BXP)Biotechnology+11.8+16
BiVictriX Therapeutics PLC (BVX)Biotechnology+21.2+4
Bioventix (BVXP)Biotechnology+2.9-9
Chill Brands Group PLC (CHLL)Biotechnology-29.4-23
Cizzle Biotechnology Holdings PLC (CIZ)Biotechnology-3.1+2
Destiny Pharma PLC (DEST)Biotechnology-7.7-30
Diaceutics PLC (DXRX)Biotechnology+1.8+22
Evgen Pharma PLC (EVG)Biotechnology-8.6-7
Faron Pharmaceuticals Oy (FARN)Biotechnology0-24
Genflow Biosciences plc (GENF)Biotechnology+15.9+21
Genincode PLC (GENI)Biotechnology-32.1-22
Genus PLC (GNS)Biotechnology+4.0+16
Haleon PLC (HLN)Biotechnology+2.1+31
Ondine Biomedical Inc (OBI)Biotechnology-22.0-23
Oxford BioMedica PLC (OXB)Biotechnology+28.4+43
Oxford Nanopore Technologies PLC (ONT)Biotechnology+22.2+11
Physiomics PLC (PYC)Biotechnology+5.7-19
Shield Therapeutics PLC (STX)Biotechnology+14.6+37
genedrive plc (GDR)Biotechnology-15.0-9

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn